Search

The article by Gina Kolata and Rebecca Robbins highlights the potential breakthrough in pancreatic cancer treatment with daraxonrasib, an experimental drug that has shown to significantly prolong patients' lives by targeting the previously deemed "undruggable" KRAS protein, signaling a major advancement in cancer therapy after decades of challenges and failures. #CancerResearch #PancreaticCancer #InnovativeMedicine #US #CA

The University of Aberdeen has secured over £1 million in funding from the British Heart Foundation to advance the development of Trodusquemine, a promising drug that may aid in treating heart disease by reducing bad cholesterol and fat in arteries, potentially offering new hope for patients with atherosclerosis who do not respond to current treatments. #HeartHealth #CardiovascularResearch #InnovativeMedicine #GB #DK #FR #NL

The University of Aberdeen has secured over £1 million in funding from the British Heart Foundation to further develop Trodusquemine, a promising drug that has shown potential in reducing bad cholesterol and fat buildup in arteries, aiming to offer new treatment options for patients with severe atherosclerosis. #HeartHealth #CardiovascularResearch #InnovativeMedicine #GB #DK #FR #NL